Long-awaited results from the DAPT
trial affirm that long-term dual-antiplatelet drug therapy is more effective than aspirin alone at preventing in-stent thrombosis and myocardial infarctions in patients treated with drug-eluting stents but also increases...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?